-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Early Detection & Screening
-
Breaking the Silence: The #HearHer Campaign for Women with Lung Cancer
Narjust Florez, MD, and Angela Morabito, BS, launched the #HearHer campaign to raise awareness about the increasing incidence of lung cancer among women and the frequent delays in diagnosis.
-
Strength in Numbers: Researchers and Advocacy Groups Unite to Decode the Impact of Genetics on Lung Cancer Risk
A new genetics study aims to collect data from 10,000 participants diagnosed with lung cancer to improve future outcomes and enhance research.
-
Data Shows Screening Programs Can Shift Stage Distribution at Diagnosis
Dr. Mike Gieske said since implementing a multidisciplinary screening approach, his healthcare system has seen a 19% decrease in late-stage lung cancers, and they now see more early-stage than late-stage lung cancers.
-
Older Age Alone Does Not Preclude Benefit From Early Detection
Dr. Matt Warkentin says in those without significant comorbidity and who are fit for surgery, screening may provide survival benefits.
-
Study Shows Patients at Lowest Risk May Benefit from Longer Intervals Between Lung Cancer Screening
Dr. Annette McWilliams says the PanCan nodule management protocol demonstrates potential to streamline lung cancer screening and management processes.
-
First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology
The session will also include late-breaking data from HARMONi-2, NeoCOAST-2, and TROPION-Lung01 as well as an address from IASLC President Dr. Paul Van Schil.
-
IASLC President-Elect Reflects on Importance of Prevention, Screening, Biomarker Testing and More
Dr. Caicun Zhou discusses his plans for WCLC 2024 as well as his goals for his time as IASLC President.
-
Screening Experts Outline Considerations for LDCT Screening Programs
Lead author Dr. Claudia Henschke says a recently published perspective from the IASLC Early Detection and Screening Committee explores several components of effective screening efforts, including timing between screenings.
-
Research Supports Use of Lung Nodule Programs to Improve Early Detection Efforts
A study by Dr. Raymond U. Osarogiagbon and colleagues found that such programs may benefit patients deemed too young or too old for lung cancer screening based on existing guidelines.
-
In Brief for January 10, 2024
As the IASLC celebrates its 50th year, the association’s journal moves to online only and the American Cancer Society recommends expanding screening eligibility.